Abstract
Background
Our current control strategies for viral infections still fall short of meeting the increasing demand for effective antiviral treatments. The evolving nature of viruses through genetic mutations often renders specific drugs ineffective against emerging strains. This research focuses on harnessing the potential of nanotechnology to develop more efficacious treatments using natural drug compounds. Curcumin, derived from Curcuma longa, is renowned for its broad therapeutic effects due to its ability to interact with various enzymes and proteins in the body. While curcumin can bind to viral proteins and inhibit their activity, it has inadequate bioavailability due to its low solubility in the aqueous gastrointestinal fluids. In contrast, curcumin nanoparticles offer improved solubility and bioavailability, enhancing our traditional approaches to control viral infections, including pandemics. Herein, curcumin nanoparticle formulations were generated using two different Curcumin nanoformulations. Specifically, curcumin was loaded onto Poly Lactic-co-Glycolic Acid (PLGA) to create the first nanoparticle Cur-PLGA. In parallel, Curcumin was combined with Zinc oxide to produce a Cur-ZnO composite. The compositions of these preparations, varying in curcumin concentrations, were verified through a series of physical and chemical assays, and then compared for their anti-SARS-CoV-2 activity.
Results
In vitro experiments revealed that the Cur-ZnO composite exhibited significantly higher anti-SARS-CoV-2 activity than Cur-PLGA, while maintaining host cell safety. Our investigation revealed that Zinc oxide surpasses PLGA in terms of Curcumin loading efficiency, significantly enhancing the effectiveness of the prepared samples across various applications. Furthermore, Cur-ZnO maintains an elevated level of safety, in contrast to the costly PLGA.
Conclusion
This study highlights the superiority of Cur-ZnO composite nanoparticles over Cur-PLGA as anti-SARS-CoV-2. It also emphasizes the robust antiviral potential of different curcumin based ZnO nanoparticles. Despite that this work highlights the significance of using the predefined nano-formulations as antivirals against SARS-CoV-2, this research primarily concentrates on the in vitro anti-viral effects. Therefore, further investigation through preclinical and clinical studies to validate these findings in vivo are still required.
Graphical Abstract
The graph clearly shows the advantage of Cur-ZnO nanoparticles over Cur-PLGA nanoparticles with a directly proportional relationship between the amount of curcumin in Cur-ZnO composite and its antiviral effect on SARS-CoV-2. The graph also illustrates the authors view about the structure of the prepared samples according to the characterizations where PLGA polymer was represented as a linear molecule, Curcumin was represented as yellow dots and ZnO was represented as hexagonal shape according to XRD analysis and HR-TEM imaging. The prepared samples are represented with respect to the previous single molecules representations as follow: Cur-PLGA representation was drew as if it is a transition section in the Cur-PLGA molecule to help in clarification of the encapsulation happened in the non-stoichiometric sample. The graph shows a hollow ring for the stoichiometric sample and a solid one for the non-stoichiometric sample. When we turn to Cur-ZnO samples as the amount of curcumin increases, it shows more yellow Curcumin dots in the hexagonal ZnO nanoparticles.
Data Availability
All data generated or analyzed during this study are included in this published article.
Abbreviations
- Cur :
-
Curcumin
- PLGA :
-
Poly lactic co-glycolic acid
- ZnO :
-
Zinc oxide
- Cur-PLGA :
-
Curcumin loaded on poly lactic co-glycolic acid
- Cur-ZnO :
-
Curcumin loaded on zinc oxide
- X = 5 :
-
Curcumin percent is 5% and ZnO percent is 95%
- X = 10 :
-
Curcumin percent is 10% and ZnO percent is 90%
- X = 20 :
-
Curcumin percent is 20% and ZnO percent is 80
References
Mousa HA (2017) Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal. Complement Nat Ther 22(1):166–174. https://doi.org/10.1177/2156587216641831
Chan JFW, To KKW, Chen H, Yuen KY (2015) Interspecies transmission and emergence of novel viruses: lessons from bats and birds Jasper. Curr Opin Virol 10(January):63–69
Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P (2020) Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes Metab Syndr: Clin Res Rev 14(4):367–382
Coopersmith CM, Antonelli M, Bauer SR, Deutschman CS, Evans LE, Ferrer R, Hellman J, Jog S, Kesecioglu J, Kissoon N, Martin-Loeches I, Nunnally ME, Prescott HC, Rhodes A, Talmor D, Tissieres P, De Backer D (2021) The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness. Crit Care Med 49(4):598–622. https://doi.org/10.1097/CCM.0000000000004895
Picot S., Marty A., Bienvenu A.-L., et al. (2020) Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID-19. One Health
Andlauer W, Fu P (2002) Nutraceuticals: a piece of history. Present Status Outlook 35:171–176
Hatcher H, Planalp R, Cho J, Torti FM, Torti SV, Curcumin (2008) From ancient medicine to current clinical trials. Cell Mol Life Sci 65(11):1631–1652. https://doi.org/10.1007/s00018-008-7452-4
Jennings MR, Parks RJ (2020) Curcumin as an Antiviral Agent. Viruses 12(11):1242. https://doi.org/10.3390/v12111242
Rahimi HR, Nedaeinia R, Shamloo AS, Nikdoust S, Oskuee K (2016) Novel delivery system for natural products. Nano-curcumin Formulations 6(4):383–398
Perera WPTD, Dissanayake RK, Ranatunga UI, Hettiarachchi NM, Perera KDC, Unagolla JM, De Silva RT, Pahalagedara LR (2020) Curcumin loaded zinc oxide nanoparticles for activity-enhanced antibacterial and anticancer applications. RSC Adv 10(51):30785–30795. https://doi.org/10.1039/d0ra05755j
**e X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, Wang H, Zhou Q, Yu S (2011) PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem 59(17):9280–9289
Seow ZL, Wong AS, Thavasi V, Jose R, Ramakrishna S, Ho GW (2009) Controlled synthesis and application of ZnO nanoparticles, nanorods and nanospheres in dye-sensitized solar cells. Nanotechnology 20(4):045604. https://doi.org/10.1088/0957-4484/20/4/045604-
Al-Ajmi MF, Hussain A (2016) Novel synthesis of ZnO nanoparticles and their enhanced anticancer activity: role of ZnO as a drug carrier. Ceram Int 42(3):4462–4469
Arefi MR, Rezaei-Zarchi S (2012) Synthesis of zinc oxide nanoparticles and their effect on the compressive strength and setting time of self-compacted concrete paste as cementitious composites. Int J Mol Sci 13(4):4340–4350. https://doi.org/10.3390/ijms13044340
Van Nong H, Hung LX, Thang PN, Chinh VD, Vu LV, Dung PT, Van Trung T, Nga PT (2016) Fabrication and vibration characterization of curcumin extracted from turmeric (Curcuma longa) rhizomes of the northern Vietnam. SpringerPlus 5(1):1147
Wijiani N, Isadiartuti D, Rijal MAS, Yusuf H (2020) Characterization and Dissolution Study of Micellar Curcumin-Spray Dried Powder for Oral Delivery. Int J Nanomedicine 15:1787–1796
Chen X, Zou LQ, Niu J, Liu W, Peng SF, Liu CM (2015) The stability, sustained release and cellular antioxidant activity of curcumin nanoliposomes. Molecules 20(8):14293–14311
Jiang P, Yu D, Zhang W, Mao Z, Gao C (2015) Influence of bovine serum albumin coated poly(lactic-co-glycolic acid) particles on differentiation of mesenchymal stem cells. RSC Adv 5(51):40924–40931. https://doi.org/10.1039/c5ra07219k
Khoshhesab ZM, Sarfaraz M, Asadabad MA (2011) Preparation of ZnO nanostructures by chemical precipitation method. Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry 41(7):814–819
Nagaraju G, Prashanth SA, Shastri M, Yathish KV, Anupama C, Rangappa DJMRB (2017) Electrochemical heavy metal detection, photocatalytic, photoluminescence, biodiesel production and antibacterial activities of Ag–ZnO nanomaterial. Mater Res Bull 94:54–63
IR-Spectroscopy Part II Published Online 2021:1–40
Textmap W Organic chemistry
Funding
This research was funded by the Egyptian Academy of Scientific Research and Technology (ASRT) within the “Ideation Fund” program under contract numbers 7303 (To A.M.). Also funded by a grant from Science and technology Development Fund (STDF-31305 centre of excellence for the production of nanomaterials), Ministry of Higher Education and Scientific Research, Egypt (To S.I. Eldek).
Author information
Authors and Affiliations
Contributions
Conceptualization, Z.A., A.A., and S.I.; methodology, Z.A., A.M., A.A., G.M., N.M.; and S.E.; validation, A.M., A.A., and S.I.; formal analysis, Z.A., A.M., and S.I.; investigation, Z.A., A.M., A.A., and S. I.; resources, Z.A., A.M., A.A., and S.I.; data correction, A.M., A.A., and S.I.; writing—original draft preparation, Z.A.; writing—review and editing, A.M., A.A., and S.I.; visualization, Z.A., A.M., and S.I.; supervision, A.M., A.A., and S.I.; project administration, A.M., A.A., and S.I.; funding acquisition, Z.A., and A.M.; All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors have no competing interests.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Elbadawy, Z.A., Mostafa, A., Ragab, G. . et al. Preparation, Characterization and Antiviral Evaluation of Nano-formulations Comprising Curcumin-PLGA and Curcumin-metal Oxide Nanocomposite against SARS-CoV-2. Chemistry Africa (2024). https://doi.org/10.1007/s42250-024-01004-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s42250-024-01004-2